Detalhe da pesquisa
1.
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Ann Oncol
; 22(5): 1078-1087, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21048039